← SynDRA
BRL-15,572
SynDRA canonical compound SYN0019063 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR1D |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
All known targets
- HTR1D
- HTR1A
- HTR1B
- HTR1E
- HTR1F
- HTR2A
- HTR2B
- HTR2C
- HTR6
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR1A PARTIAL AGONIST
- HTR1B PARTIAL AGONIST
- HTR1D PARTIAL AGONIST
- HTR1E PARTIAL AGONIST
- HTR1F PARTIAL AGONIST
- HTR2A FULL AGONIST
- HTR2B PARTIAL AGONIST
- HTR2C PARTIAL AGONIST
- HTR6 PARTIAL AGONIST
- 5-ht1d receptor antagonist
- HTR1F AGONIST
Cross-references
Synonyms
- BRL 15572
- BRL15572
- BRL-15572
- 3-(4-(3-Chlorophenyl)piperazin-1-yl)-1,1-diphenyl-2-propanol
- RefChem:121445
- BRL-15572free
- 3-[4-(3-chlorophenyl)piperazin-1-yl]-1,1-diphenylpropan-2-ol
- 3-(4-(3-Chlorophenyl)piperazin-1-yl)-1,1-diphenylpropan-2-ol
- BRL-15572 free
- CHEBI:64060
- J878.866I
- LY8CZE6XUD
- 3-(4-(3-Chlorophenyl)-1-piperazinyl)-1,1-diphenyl-2-propanol
- UNII-LY8CZE6XUD
- Biomol-NT_000118
- GTPL10
- Lopac0_000185
- BPBio1_000265
- SCHEMBL7741355
- BDBM85165
- JEB51740
- HY-13200B
- PDSP1_000534
- PDSP2_000532
- AKOS037649318
- CCG-204280
- SB19509
- SDCCGSBI-0050173.P002
- NCGC00015173-02
- NCGC00015173-03
- NCGC00015173-04
- NCGC00015173-05
- NCGC00015173-08
- NCGC00025039-02
- NCGC00025039-03
- BS-18031
- DB-377904
- CS-0141997
- E74570
Look up BRL-15,572 in the interactive SynDRA portal →